v3.25.4
Supplemental Financial Information
 12 Months Ended
Dec. 31, 2025
Other Balance Sheet Details [Abstract]  
Supplemental Financial Information Supplemental Financial Information
Prepaid expenses consisted of the following:
December 31,
(in millions)20252024
Prepaid income taxes$94.0 $— 
Prepaid development costs55.6 32.1 
Other prepaid expenses21.1 16.4 
Total prepaid expenses$170.7 $48.5 
Inventory consisted of the following:
December 31,
(in millions)20252024
Raw materials$35.7 $33.7 
Work in process19.2 10.9 
Finished goods14.3 12.8 
69.2 57.4 
Less inventory reserves
(0.2)— 
Total inventory$69.0 $57.4 
Property and equipment, net, consisted of the following:
December 31,
(in millions)20252024
Scientific equipment$123.3 $95.7 
Computer equipment28.9 38.9 
Tenant improvements35.6 35.9 
Furniture and fixtures20.3 18.6 
208.1 189.1 
Less accumulated depreciation(118.3)(106.5)
Total property and equipment, net$89.8 $82.6 
Accounts payable and accrued liabilities consisted of the following:
December 31,
(in millions)20252024
Sales rebates and reserves$226.0 $144.2 
Accrued employee related costs128.8 107.5 
Accrued development costs
101.3 50.8 
Current income taxes payable
68.0 10.0 
Current branded prescription drug fee45.3 49.2 
Accounts payable and other accrued liabilities104.9 99.9 
Total accounts payable and accrued liabilities$674.3 $461.6 
Other noncurrent liabilities consisted of the following:
December 31,
(in millions)20252024
Noncurrent income taxes payable
$214.5 $160.7 
Other noncurrent liabilities5.2 5.5 
Total other noncurrent liabilities$219.7 $166.2 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown on the consolidated statements of cash flows.
December 31,
(in millions)20252024
Cash and cash equivalents$713.0 $233.0 
Restricted cash included in other noncurrent assets
8.0 8.0 
Total cash, cash equivalents, and restricted cash$721.0 $241.0